BergenstalRM, BashanE, McShaneM, JohnsonM, HodishI. Can a tool that automates insulin titration be a key to diabetes management?Diabetes Technol Ther, 2012; 14:675–682.
2.
FrenchJRP. Field experiments: changing group productivity. MillerJG. Experiments in Social Process: A Symposium on Social Psychology. New York: McGraw-Hill, 1950; 82.
3.
ChanochLH, JovanovicL, PetersonCM. The evaluation of a pocket computer as an aid to insulin dose determination by patients. Diabetes Care, 1985; 8:172–176.
4.
ZisserH, JovanovicL, DoyleF3rd, OspinaP, OwensC. Run-to-run control of meal-related insulin dosing. Diabetes Technol Ther, 2005; 7:48–57.
5.
ZisserHC, BevierWC, JovanovicL. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Diabetes Technol Ther, 2007; 9:509–515.
6.
PalermCC, ZisserH, JovanovičL, DoyleFJ3rd. A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes. J Process Control, 2008; 18:258–265.
7.
BevierWC, ZisserHC, JovanovicL, FinanDA, PalermCC, SeborgDE, DoyleFJ3rd. Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabetes Sci Technol, 2008; 2:578–583.
8.
GargSK, BookoutTR, McFannKK, KellyWC, BeatsonC, EllisSL, GutinRS, GottliebPA. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technol Ther, 2008; 10:369–375.
9.
BergenstalRM, JohnsonM, PowersMA, WynneA, VlajnicA, HollanderP, RendellM. Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care, 2008; 31:1305–1310.
10.
HermanWH, IlagLL, JohnsonSL, MartinCL, SindingJ, Al HarthiA, PlunkettCD, LaPorteFB, BurkeR, BrownMB, HalterJB, RaskinP. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care, 2005; 28:1568–1573.
11.
HolmanRR, FarmerAJ, DaviesMJ, LevyJC, DarbyshireJL, KeenanJF, PaulSK. 4-T Study Group. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med, 2009; 361:1736–1747.
12.
KennedyL, HermanWH, StrangeP, HarrisA. GOAL AIC Team. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care, 2006; 29:1–8.
13.
OyerDS, ShepherdMD, CoulterFC, BhargavaA, BrettJ, ChuPL, TrippeBS. INITIATEplus Study Group. A1c control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus Trial)Am J Med, 2009; 122:1043–1049.
14.
DassauE, JovanovicL, DoyleFJ3rd, ZisserHC. Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia—monitor, alert, and locate. J Diabetes Sci Technol, 2009; 3:1501–1506.
15.
RiglaM. Smart telemedicine support for continuous glucose monitoring: the embryo of a future global agent for diabetes care. J Diabetes Sci Technol, 2011; 5:63–67.